← Back to Search

Behavioral Intervention

Pharmacist-Led Management for Type 2 Diabetes

N/A

Waitlist Available

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults (age 18 and older) with type 2 diabetes with HbA1C 10 % or above

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and through study completion at 10 months approximately

Awards & highlights

Study Summary

This trialstudies how diabetes can be improved with diet, exercise, & meds. A team of health experts will help patients manage their diabetes which will be measured over 3 months.

Who is the study for?

This trial is for adults over 18 with uncontrolled type 2 diabetes (HbA1C of 10% or higher) who are willing to adjust medications, monitor blood glucose at home, and have not had pharmacist-directed interventions before. They must be patients of the Portage Clinic and consent to participate fully.Check my eligibility

What is being tested?

The study evaluates how effective pharmacists' interventions are in managing type 2 diabetes by looking at changes in HbA1C levels and patient self-management skills through surveys. It involves behavioral strategies and approved diabetes drugs.See study design

What are the potential side effects?

While specific side effects aren't listed, typical ones from diabetes medications can include low blood sugar, upset stomach, skin reactions, weight gain, kidney issues, dizziness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult with type 2 diabetes and my HbA1C level is 10% or above.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and through study completion at 10 months approximately

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and through study completion at 10 months approximately

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and through study completion at 10 months approximately for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Baseline Hemoglobin A1C (HbA1C) at 10 months

Secondary outcome measures

Modifiable Risk Factor - Blood Pressure

Modifiable Risk Factor - Body Mass Index

Modifiable Risk Factors -Cholesterol Level

+1 more

Trial Design

2Treatment groups

Active Control

Group I: Control ArmActive Control1 Intervention

The participants in this arm will receive standard of care from their physician as they would have been doing previously. This still may involve blood work, referrals to other health providers (except pharmacist) and medication adjustments driven by the pharmacist.

Group II: Pharmacist Intervention ArmActive Control1 Intervention

The participants in this arm will receive standard of care from their physician in addition to pharmacist intervention. The pharmacist or pharmD intern leads the diabetes care for the patient typically, conducting a medication review, recommending medication changes, frequent follow up and requesting blood work and providing referrals to other health care providers as needed,which is standard care

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor

595 Previous Clinical Trials

199,462 Total Patients Enrolled

6 Trials studying Diabetes

3,518 Patients Enrolled for Diabetes

Media Library

Behavioral and drugs already approved and available for diabetes management (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05442840 — N/A

Diabetes Research Study Groups: Control Arm, Pharmacist Intervention Arm

Diabetes Clinical Trial 2023: Behavioral and drugs already approved and available for diabetes management Highlights & Side Effects. Trial Name: NCT05442840 — N/A

Behavioral and drugs already approved and available for diabetes management (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05442840 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of patients that will be a part of this research project?

"Yes, the most recent information on clinicaltrials.gov supports that this trial is still recruiting patients. The trial was first posted on 7/4/2022 and was last edited on 10/31/2022. The study is looking for 60 participants from 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes

2022. "Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05442840.